Aspergillus terreus

  • Allergen search puff


    Search ImmunoCAP allergens and allergen components. Note that all information is in English.

Code: m36
Latin name: Aspergillus terreus
Source material: Spores and mycelium
Family: Trichocomaceae

For continuous updates:


A mould, which may result in allergy symptoms in sensitised individuals.

Allergen Exposure

Aspergillus species are widely distributed in nature; they have been isolated predominantly from soils, decaying vegetation and a wide variety of organic matter. (1) Although the genus Aspergillus contains over 150 species, only a few are considered to be pathogenic for humans. More than 30 species have been implicated in different human and animal infections. (1) 

Aspergillus terreus is a fungus that is widespread throughout the world and found in warm arable soils; and found more commonly in cultivated soils than the forest. It is rarely found in the acidic forest soils from the colder temperate zone. A. terreus is distinguished from the more common Aspergillus species by its compactly columnar, cinnamon to tan (sometimes yellowish to orange-brown) conidial heads, and tan to yellow colouration. (Cited in 2) A. terreus, A. carneus, A. flavipes, and A. niveus are unique among Aspergillus species, as they produce morphologically distinct lateral conidia (aleurioconidia) in infected tissue. These conidia are usually attached directly to a very short lateral extension of the hyphae and are generally borne singly, although multiple conidia can be formed from a single locus. (Cited in 2)

A. terreus is also commonly found in aerobiological surveys, and has been demonstrated to occur in air-conditioned rooms. (3, 4)

A. terreus is commonly used in industry to produce important organic acids, such as itaconic acid and cis-aconitic acid. It was also the initial source for the drug mevinolin (lovastatin), a drug for lowering serum cholesterol. A. terreus may cause opportunistic infection in people with deficient immune systems, but may also cause disease in immunocompetent individuals. It is refractory to amphotericin B therapy.

Infection with A. terreus is more likely to result in invasive, disseminated disease than infection with other Aspergillus species; importantly, this species appears to be less susceptible to the antifungal drug amphotericin B. Unique to this species is the ability to produce specialised structures – denoted accessory conidia (AC) – directly on hyphae, both in vitro and in vivo. (5)

Allergen Description

No allergens have been characterised.

A number of proteins (including heat shock protein 90 (6) and heat shock protein 60 (7) that have been shown to have allergenic potential in other fungi have been isolated, but their allergenic potential has not yet been elucidated. An alkaline protease enzyme has been isolated which is related to that of Aspergillus fumigatus. (8)

Importantly, A. terreus does not appear to contain an allergen related to Asp f 1, a major 18 kDa allergen of A. fumigatus and a member of the mitogillin family of cytotoxins, which is also 99% homologous to mitogillin from Aspergillus restrictus. (9)

Potential Cross-Reactivity

A. terreus, A. flavus and A. nidulans hydrolyse collagen and were found to secrete an alkaline protease related to that of A. fumigatus. In contrast, A. niger, A. glaucus, A. versicolor and A. clavatus were unable to degrade collagen in vitro, suggesting a possible pathogenic role for the secreted alkaline proteases of the Aspergillus species.(8) The allergenic potential of this alkaline protease was not evaluated, but may be similar to that of other alkaline proteases that are recognised allergens in other fungal species.

Clinical Experience

IgE-mediated reactions

Anecdotal evidence suggests that Aspergillus terreus may induce symptoms of hypersensitivity, including asthma, allergic alveolitis and hypersensitivity pneumonitis in sensitised individuals. (10) However, few studies have been reported to date; it is possible that the allergy occurs more frequently than has been reported. A. terreus has been recognised as a cause of allergic bronchopulmonary aspergillosis. (11, 12)

A farmer who had developed severe respiratory as well as systemic symptoms upon exposure to hay dust was shown by inhalation challenge (utilising his own hay) to experience peripheral and central airway obstruction beginning immediately after challenge, as well as the development of symptoms of typical hypersensitivity pneumonitis reaction several hours later. Immunodiffusion studies demonstrated serum precipitins to antigenic components of this hay, which were identified as antigens of several Aspergillus species. Further analysis isolated ten relevant antigens of A. terreus and four of A. fumigatus. Only minimal Aspergillus-specific IgE antibodies were found in the patient's serum. The authors concluded that this case demonstrates that hay dust can cause bronchial obstruction as well as hypersensitivity pneumonitis in the same individual, with symptoms beginning immediately and lasting up to 2 days. (10)

Farmer’s lung as a result of A. fumigatus, A terreus and Nocardiopsis alba has been documented in a farmer and his son. (13)

A 16-year-old male with a history of asthma and recurrent pneumonia was diagnosed with allergic bronchopulmonary aspergillosis (ABPA), based upon the typical clinical presentation of peripheral eosinophilia, elevated IgE and positive immediate skin tests to Aspergillus. Sputum cultures grew A. terreus. Precipitins against A. terreus (but not against A. fumigatus) were detected in the patient's serum. His lymphocytes proliferated markedly in vitro when exposed to soluble A. terreus antigen, but not when exposed to A. fumigatus antigen. (14)

In patients with allergic respiratory diseases, there is heterogeneity of immune response to different species of Aspergillus. (15) In a study of the allergenic significance of 13 species of Aspergillus and their allergenic and antigenic relationship, after skin-prick testing on 289 patients with allergic respiratory diseases, 627 (20.7%) were positive and 12.8% significantly positive. Of the 64 patients eliciting a positive cutaneous response to at least one species, 42 (65.6%) were positive to 5 or fewer species while others showed a broad spectrum of positive skin reactivity to different Aspergillus extracts. The presence of both species-specific allergenic components and those shared between different Aspergillus species was demonstrated. (15)

Other reactions

A. terreus has been recognised as a cause of aspergilloma, (16, 17) onychomycosis, (18, 19) aural cavity disease, (20, 21, 22, 23, 24, 25) subcutaneous abscesses, (26, 27) and keratitis. (28, 29)

Invasive fungus infections caused by Aspergillus spp. may occur in immuno-competent hosts, but occur most frequently in immunocompromised patients. (30) A high infection-associated death rate of up to and over 50% is attributed to these fungi. Although disease in humans is caused mainly by A. fumigatus, A. flavus and A. niger, other species (such as A. terreus and A. nidulans) occur but are less prevalent. (31) A retrospective single-centre study of invasive fungal infections in 1 095 patients with haematological malignancies found that A. fumigatus (n = 46) and A. terreus (n = 41) were the predominant causes. (32)

However, an increase in the rates of infection caused by A. terreus has been observed, including in Japan. (33) A. terreus appears to have become an increasingly frequent cause of opportunistic infections at the University Hospital of Innsbruck, Austria, (34) and has been implicated even in dryer climates such as that of Kuwait. (35)

A 12-year retrospective study identified 13 cases of invasive aspergillosis caused by A. terreus, of which 11 were primary pulmonary infections and 2 were primary peritoneal infections; all patients had malignancy. (36) In another study (1997-2002), 83 cases of A. terreus infection from three medical centres were described. (37) Cases of infective endocarditis, (38, 39, 40) myocarditis, (41) meningitis, (42) brain abscess, (43) osteomyelitis, (44) discitis, lymphadenitis, (45) endophthalmitis, (46) mycotic aortic aneurysm and peritonitis (47, 48) due to A. terreus have been reported. (49, 50, 51, 52, 53)

Other conditions reported to occur as a result of A. terreus include granulomatosis (54) or infection of the ear, nose and throat, (55) following transplantation of organs (56) or in patients who are receiving immunosuppressive drugs. (57)

Infection of patients with cystic fibrosis with A. terreus has been reported. (58) A. fumigatus, Scedosporium apiospermum and A. terreus (for filamentous fungi) and Candida albicans (for yeasts) are reported to be the main fungal species associated with cystic fibrosis. (59) Similarly, this organism may infect patients with COPD who are receiving corticoids. (60)

Significantly, invasive infections caused by this organism are often disseminated with increased lethality compared to infections caused by other Aspergillus species, and tend to be resistant to treatment with the antifungal drug amphotericin B. (61)

A Japanese study reported that in fungal infections of the ear and nose, A. terreus was the most common pathogen of otomycosis, followed by A. niger and A. flavus; aspergillosis was the most common fungal disease in the paranasal sinuses. (62)

Although cutaneous infections due to A. terreus are rare they may occur, as described in a paediatric patient with cutaneous infections who had undergone surgical treatment for an open tibial fracture secondary to an agricultural accident. (47) Keratitis has been described. (63)

Compiled by Dr Harris Steinman.


  1. Sigler L, Verweij P. Aspergillus, Fusarium, and other opportunistic moniliaceous fungi. In Manual of Clinical Microbiology, 2003:1726–39. Edited by P. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller & R. H. Yolken. Washington, DC: American Society for Microbiology.
  2. Steinbach WJ, Perfect JR, Schell WA, Walsh TJ, Benjamin DK Jr. In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob Agents Chemother 2004;48(9):3217-25.
  3. Singh AB, Kumar P. Common environmental allergens causing respiratory allergy in India. Indian J Pediatr 2002;69(3):245-50.
  4. Khan A, Karuppayil S, Manoharachary C, Kunwar I, Waghray S. Isolation, identification and testing for allergenicity of fungi from air-conditioned indoor environments. Aerobiologia 2009;25(2):119-23.
  5. Deak E, Wilson SD, White E, Carr JH, Balajee SA. Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics. PLoS One. 2009;4(10):e7673.
  6. Cowen LE, Singh SD, Köhler JR, Collins C, Zaas AK, Schell WA, Aziz H, Mylonakis E, Perfect JR, Whitesell L, Lindquist S. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A 2009;106(8):2818-23.
  7. Raggam RB, Salzer HJ, Marth E, Heiling B, Paulitsch AH, Buzina W. Molecular detection and characterisation of fungal heat shock protein 60. Mycoses 2010 Jul 28. [Epub ahead of print]
  8. Hanzi M, Shimizu M, Hearn VM, Monod M. A study of the alkaline proteases secreted by different Aspergillus species. Mycoses 1993;36(11-12):351-6.
  9. Arruda LK, Mann BJ, Chapman MD. Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases. J Immunol 1992;149(10):3354-9.
  10. Baur X, Dexheimer E. Hypersensitivity pneumonitis concomitant with acute airway obstruction after exposure to hay dust. Respiration 1984;46(4):354-61.
  11. Laham MN, Carpenter JL. Aspergillus terreus, a pathogen capable of causing infective endocarditis, Pulmonary mycetoma, and allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1982;125(6):769-72.
  12. Vincken W, Schandevul W, Roels P. Allergic bronchopulmonary aspergillosis caused by Aspergillus terreus. Am Rev Respir Dis 1983;127(3):388-9.
  13. Imai K, Ashitani J, Imazu Y, Yanagi S, Sano A, Tokojima M, Nakazato M. Farmer's lung cases of a farmer and his son with high BAL fluid beta-D glucan levels. [Japanese] Nihon Kokyuki Gakkai Zasshi. 2004;42(12):1024-9.
  14. Laham MN, Allen RC, Greene JC. Allergic bronchopulmonary aspergillosis (ABPA) caused by Aspergillus terreus: specific lymphocyte sensitization and antigen-directed serum opsonic activity. Ann Allergy 1981;46(2):74-80.
  15. Aggarwal S, Chhabra SK, Saxena RK, Agarwal MK. Heterogeneity of immune responses to various Aspergillus species in patients with allergic respiratory diseases. Indian J Chest Dis Allied Sci 2000;42(4):249-58.
  16. Kennedy WP, Milne LJ, Blyth W, Crompton GK. Two unusual organisms, Aspergillus terreus and Metschnikowia pulcherrima associated with the lung disease of ankylosing spondylitis. Thorax 1972;27(5):604-10.
  17. Khan ZU, Kortom M, Marouf R, Chandy R, Rinaldi MG, Sutton DA. Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus. J Clin Microbiol 2000;38(5):2010-4.
  18. Onsberg P, Stahl D, Veien NK. Onychomycosis caused by Aspergillus terreus. Sabouraudia 1978;16(1):39-46.
  19. Zaias N. Onychomycosis. Arch. Dermatol 1972;105:263-74.
  20. Egami T, Noguchi M, Ueda S. Mycosis in the ear, nose and throat. [Japanese] Nippon Ishinkin Gakkai Zasshi. 2003;44(4):277-83.
  21. English MP, Dalton GA. An outbreak of fungal infections of post-operative aural cavities. J Laryngol Otol 1962;76:1-11.
  22. Gregson AE, La Touche CJ. The significance of mycotic infection in the aetiology of otitis externa. J Laryngol Otol 1961;75:167-70.
  23. Powell DEB, English MP, and Duncan EHL. Clinical, bacteriological and mycological findings in postoperative ear cavities. J Laryngol Otol 1962;76:12-21.
  24. Suseelan AV, Gugnani HC, Ojukwu JO. Primary cutaneous aspergillosis due to Aspergillus terreus. [Letter] Arch Dermatol 1976;112:1468.
  25. Tiwari S, Singh SM, Jain S. Chronic bilateral suppurative otitis media caused by Aspergillus terreus. Mycoses 1995;38:297-300.
  26. Cheetham HD. Subcutaneous infection due to Aspergillus terreus. J Clin Pathol 1964;17:251-3.
  27. Sukroongreung S, Thakerngpol K. Abnormal form of Aspergillus terreus isolated from mycotic abscesses. Mycopathologica 1985;91:47-52.
  28. Rosa RH, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in South Florida. Ophthalmology 1994;101:1005-13.
  29. Singh SM, Sharma S, Chatterjee PK. Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model. Mycopathologica 1990;112:127-37.
  30. Baddley JW, Pappas PG, Smith AC, Moser SA. Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 2003;41(12):5525-9.
  31. Karthaus M. Guideline based treatment of invasive aspergillosis. [German] Mycoses 2010;53 Suppl 1:36-43.
  32. Auberger J, Lass-Flörl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, Einsele H, Gastl G, Nachbaur D. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2008;88(5):508-15.
  33. Obata S, Hirata Y, Sunakawa K, Inoue M. An epidemiological study for fungus isolation during the twenty-five year periods from 1976 to 2000 in Kitasato University Hospital. [Japanese] Kansenshogaku Zasshi 2001;75(10):863-9.
  34. Blum G, Perkhofer S, Grif K, Mayr A, Kropshofer G, Nachbaur D, Kafka- Ritsch R, Dierich MP, Lass-Flörl C. A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infect 2008;14(12):1146-51.
  35. Khan ZU, Chugh TD. Invasive fungal infections in Kuwait: A retrospective study. Indian J Chest Dis Allied Sci 2000;42(4):279-87.
  36. Iwen PC, Rupp ME, Langnas AN, Reed EC, Hinrichs SH. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 1998;26(5):1092-7.
  37. Steinbach WJ, Benjamin DK, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJ. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 2004;39,192-8.
  38. Drexler L, Rytel M, Keelan M, Bonchek LI, Olinger GN. Aspergillus terreus infective endocarditis on a porcine heterograft valve. J Thorac Cardiovasc Surg 1980;79,269-74.
  39. Chim CS, Ho PL, Yuen ST, Yuen KY. Fungal endocarditis in bone marrow transplantation: case report and review of literature. J Infect 1998;37(3):287-91.
  40. Verghese S, Maria CF, Mullaseri AS, Asha M, Padmaja P, Padhye AA. Aspergillus endocarditis presenting as femoral artery embolism. Mycoses 2004;47(5-6):252-6.
  41. Russack V. Aspergillus terreus myocarditis: report of a case and review of the literature. Am J Cardiovasc Pathol 1990;3,275-79.
  42. Genzen JR, Kenney B. Central nervous system Aspergillus infection after epidural analgesia: diagnosis, therapeutic challenges, and literature review. Diagn Microbiol Infect Dis 2009;65(3):312-8.
  43. Damek DM, Lillehei KO, Kleinschmidt-DeMasters BK. Aspergillus terreus brain abscess mimicking tumor progression in a patient with treated glioblastoma multiforme. Clin Neuropathol 2008;27(6):400-7.
  44. Natesan S, Abraham G, Mathew M, Lalitha MK, Srinivasan CN. Secondary sternal Aspergillus osteomyelitis in a diabetic hemodialysis patient with previous allograft rejection. Hemodial Int. 2007;11(4):403-5.
  45. Mahgoub el-S, Ismail SA, el-Hassan AM. Cervical lymphadenitis caused by Aspergillus terreus. BMJ 1969;1(5645):689-90.
  46. Moinfar N, Smiddy WE, Miller D, Miller D, Herschel K. Posttraumatic Aspergillus terreus endophthalmitis masquerading as dispersed lens fragments. J Cataract Refract Surg 2007;33(4):739-40.
  47. Verghese S, Palani R, Thirunavakarasu N, Chellamma T, Pathipata P. Peritonitis due to Aspergillus terreus in a patient undergoing continuous ambulatory peritoneal dialysis. Mycoses 2008;51(2):174-6.
  48. Kalishian Y, Miller EB, Kagan A, Landau Z. Aspergillus terreus peritonitis in a CAPD patient: report of a case. Perit Dial Int 2004;24(1):93.
  49. Silva ME, Malogolowkin MH, Hall TR, Sadeghi AM, Krogstad P. Mycotic aneurysm of the thoracic aorta due to Aspergillus terreus: case report and review. Clin Infect Dis 2000;31(5):1144-8.
  50. Park KU, Lee HS, Kim CJ, Kim EC. Fungal discitis due to Aspergillus terreus in a patient with acute lymphoblastic leukemia. J Korean Med Sci 2000;15(6):704-7.
  51. Stein SC, Corrado ML, Friedlander M, Farmer P. Chronic mycotic meningitis with spinal involvement (arachnoiditis): a report of five cases. Ann Neurol 1982;11(5):519-24.
  52. Glotzbach RE. Aspergillus terreus infection of pseudoaneurysm of aortofemoral vascular graft with contiguous vertebral osteomyelitis. Am J Clin Pathol 1982;77(2):224-7.
  53. Rubio Alvarez J, Sierra Quiroga J, Rubio Taboada C, Fernandez Gonzalez A, Martinon Torres F, Garcia-Bengochea J. Cardiac Aspergillosis with pedunculated mass in the left ventricle. Tex Heart Inst J 2004;31(4):439-41.
  54. Yano S, Shishido S, Kobayashi K, Nakano H, Kawasaki Y. Bronchocentric granulomatosis due to Aspergillus terreus in an immunocompetent and non-asthmatic woman. Respir Med. 1999;93(9):672-4.
  55. Aneja KR, Sharma C, Joshi R. Fungal infection of the ear: a common problem in the north eastern part of Haryana. Int J Pediatr Otorhinolaryngol. 2010;74(6):604-7.
  56. Walter J, Sobottka I, Rogiers X, Broering D, Fischer L. Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin. Mycoses 30 Dec 2009. [Epub ahead of print]
  57. Ozer B, Kalaci A, Duran N, Dogramaci Y, Yanat AN. Cutaneous infection caused by Aspergillus terreus. J Med Microbiol 2009;58(Pt 7):968-70.
  58. Cimon B, Zouhair R, Symoens F, Carrère J, Chabasse D, Bouchara JP. Aspergillus terreus in a cystic fibrosis clinic: environmental distribution and patient colonization pattern. J Hosp Infect 2003;53(1):81-2.
  59. Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, Bouchara JP. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. Med Mycol 2009;47(4):387-97.
  60. Jara-Palomares L, Mateos I, Barrot-Cortés E, Cisneros JM. Aspergillus terreus infection in COPD patients receiving corticoids. A report of three cases. [Spanish] Enferm Infecc Microbiol Clin. 2007;25(6):415.
  61. Balajee SA, Baddley JW, Peterson SW, Nickle D, Varga J, Boey A, Lass-Flörl C, Frisvad JC, Samson RA; ISHAM Working Group on A. terreus. Aspergillus alabamensis, a new clinically relevant species in the section Terrei. Eukaryot Cell 2009;8(5):713-22.
  62. Kaieda S. Fungal infection in the otorinolaryngologic area. [Japanese] Nippon Rinsho 2008;66(12):2290-3.
  63. Xie L, Zhai H, Shi W, Zhao J, Sun S, Zang X. Hyphal growth patterns and recurrence of fungal keratitis after lamellar keratoplasty. Ophthalmology. 2008;115(6):983-7.



As in all diagnostic testing, the diagnosis is made by the physican based on both test results and the patient history.